CORRECTION: Fuzzy Logic Software Corporation and BioSecure Crops Inc.: Germans, Canadians Co-operate in Biotechnology Innovation.Business Editors TORONTO--(BUSINESS WIRE)--March 13, 2002 In the press release issued yesterday March 12, 2002, one of the email addresses See Internet address. listed for BioSecure Crops Inc. was incorrect. The complete and correct version of the release follows below. A Canadian company may have found the ideal solution to environmental concerns about genetically modified genetically modified Adjective (of an organism) having DNA which has been altered for the purpose of improvement or correction of defects genetically modified genetic adj [food etc] → field crops. BioSecure Crops Inc. of Toronto, recently acquired by FuzzyLogic Software Corp. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :FZZY), announced today that it has been contracted by MPB MPB Musica Popular Brasileira MPB Mountain Pine Beetle MPB Male Pattern Baldness MPB Most Precious Blood (band) MPB Mississippi Public Broadcasting MPB Ministry of Planning and Budget (South Korea) Cologne GmbH to test the feasibility of growing potato mini-tubers containing pharmaceutical proteins (Industrial Tubers(TM)) in contained-environment grow chambers. A series of contained-environment grow chambers will be constructed using the proprietary GroWmax(TM) technology to establish production of mini-tubers supplied by MPB Cologne. Upon completion of the nine-month feasibility study The analysis of a problem to determine if it can be solved effectively. The operational (will it work?), economical (costs and benefits) and technical (can it be built?) aspects are part of the study. Results of the study determine whether the solution should be implemented. , BioSecure will construct a production scale facility. The location of the facility has not been finalized. BioSecure Crops will assist MPB Cologne to address the worldwide shortage of antibody manufacturing capacity created by the successful entry into the market of therapeutic antibodies. The worldwide therapeutic antibody market is expected to grow from $3-billion U.S. in 2001 to $24-billion U.S. by 2010. BioSecure Crops utilizes proprietary technologies to create fully contained growing environments that maximize the output of plant biomass and allow for completely controlled plant production. Plant growing environments can be easily scaled from research to commercial-sized production and can be built anywhere regardless of location or season. "I am very optimistic op·ti·mist n. 1. One who usually expects a favorable outcome. 2. A believer in philosophical optimism. op that the GroWmax(TM) technology will prove to be the best fit for MPB Cologne's focus on biological safety in plant-made pharmaceuticals," said Klaus During, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of MPB Cologne. "It allows for maximum flexibility and promises the highest efficiency in production of Industrial Tubers(TM). Exclusive access to the GroWmax(TM) technology for the growing of mini-tubers strengthens the competitive position of both companies." "We feel that MPB's Industrial Tuber tuber, enlarged tip of a rhizome (underground stem) that stores food. Although much modified in structure, the tuber contains all the usual stem parts—bark, wood, pith, nodes, and internodes. (TM) fits well with BioSecure's technology and will prove to be an excellent platform for the commercial-scale production of a wide range of recombinant proteins Since human recombinants have replaced the animal version in human therapeutics, the prefix of "rh" for "human recombinant" appears less and less in the literature Human recombinants that replaced animal or harvested from human types About MPB Cologne: MPB Cologne GmbH manufactures new proteins in Industrial Tubers(TM) by using the potato as a plant bioreactor bioreactor a container in which living organisms carry out a biological reaction. for economical large-scale production. Customers from pharmaceutical, biotechnological and chemical industries will benefit from the comprehensive gene to protein approach of MPB Cologne. MPB has successfully proved the functional equivalence of a scFv antibody produced in Industrial Tubers(TM) in neurite outgrowth from cultured neurons Neurons Nerve cells in the brain, brain stem, and spinal cord that connect the nervous system and the muscles. Mentioned in: Speech Disorders . Upon completion of its first pilot scale productions by mid 2002, purified scFv antibodies will be available in quantities of several tens of grams. More information about MPB Cologne is available at the company web site www.mpb-cologne.com. About BioSecure Crops Inc. BioSecure Crops is a biotechnology infrastructure company serving the rapidly growing plant-based recombinant protein-manufacturing sector. BioSecure uses proprietary GroWmax(TM) plant growing technology to economically maximize biomass production in fully contained environments. Plants can produce a wide range of high value proteins such as antibodies and enzymes which can be used as vaccines or for a variety of diagnostic and therapeutic purposes. For more information about BioSecure Crops Inc. visit the company web site at www.growmax.biz This press release may contain forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. . These statements are subject to a number of risks and uncertainties that may cause actual results to differ materially from those contemplated by the forward-looking statements. Such forward-looking statements are inherently subject to risks and uncertainties beyond BioSecure's control, including, but not limited to, economic and financial conditions globally, regulatory developments in Canada and elsewhere, technological developments and competition. These and other factors may cause BioSecure's actual performance to differ materially from that contemplated by forward-looking statements, and the reader is therefore cautioned not to place undue reliance on such statements. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion